Five Ways Study Sites Benefit from Remote Monitoring

10/16/2020 By Andrea

Authored and contributed to PharmaLeaders by Jeff Pool, VP of Revenue at Florence Healthcare Failed remote site access and monitoring attempts have left study sites with a computer full of access portals, FTP logins, document vaults, and emails. Why do sponsor remote site access and monitoring rollouts fail? Because the sponsor focuses on solving their […]

Going Virtual

08/05/2020 By Andrea

Contributing Author: Chris Mycek, President at WORLEY Pivoting to virtual….Google it, you’ll find it’s a common current theme that will have enduring repercussions on how things get done. Zoom is a new household word, and now a verb as well. Amazon Prime, Netflix, FedEx, are all booming. Nesting at home, with new entertainment centers, pools, […]

HiFiBiO partners with Pharmsynthez and IBCh to develop and commercialise SARS-CoV-2 neutralising antibody in Russia

11/24/2020

The partnership aims to advance HFB30132A, a SARS-CoV-2 neutralizing antibody for the treatment of COVID-19, through clinical development and commercial sale in Russia, pending approval from the Ministry The post HiFiBiO partners with Pharmsynthez and IBCh to develop and commercialise SARS-CoV-2 … [Read More...]

Pfizer doses first participant in phase 3 study evaluating anti-TFPI investigational therapy

11/24/2020

BASIS is a global Phase 3, open-label, multicenter study that will evaluate annualized bleed rate (ABR) through 12 months on prophylaxis treatment with marstacimab, an investigational, novel subcutaneous The post Pfizer doses first participant in phase 3 study evaluating anti-TFPI investigational … [Read More...]

Merck to buy biopharmaceutical firm OncoImmune for $425m

11/24/2020

Under the deal, OncoImmune shareholders will be eligible to secure sales-based payments and payments contingent on the achievement of certain regulatory milestones. Recently, the biopharmaceutical company announced positive The post Merck to buy biopharmaceutical firm OncoImmune for $425m appeared … [Read More...]

GSK begins patient dosing in phase 3 trial of RSV maternal candidate vaccine

11/24/2020

RSV is responsible for respiratory infections such as bronchiolitis and viral pneumonia in infants. It is estimated that in the world, 33 million cases of RSV occur in The post GSK begins patient dosing in phase 3 trial of RSV maternal candidate vaccine appeared first on Pharmaceutical Business … [Read More...]

Featured Article

Five Ways Study Sites Benefit from Remote Monitoring

Going Virtual

White Papers

Managing the Shifting Currents of Customer Master Data

The Future of Professional Medical Education

Industry News

HiFiBiO partners with Pharmsynthez and IBCh to develop and commercialise SARS-CoV-2 neutralising antibody in Russia

Pfizer doses first participant in phase 3 study evaluating anti-TFPI investigational therapy

Merck to buy biopharmaceutical firm OncoImmune for $425m

GSK begins patient dosing in phase 3 trial of RSV maternal candidate vaccine